Providing expert guidance on the selection and design of reactor systems for a diverse range of chemistries, including batch and semi-batch reactions, continuous flow unit operations, hydrogenation (fixed-bed, slurry, and high-pressure systems), peptide synthesis reactors (SPPS), and oligonucleotide synthesis platforms. The Lilly Medicine Foundry Process Engineering organization is responsible for the chemistry, formulation, analytical, and engineering efforts to support development and scale-up of investigational small molecules to support clinical and toxicology studies through late-stage clinical trials.